Kingdon Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Hold |
0
| – | – | – | 110 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 98 |
|
2016
Q1 | – | Sell |
-120,142
| Closed | -$4.81M | – | 99 |
|
2015
Q4 | $4.81M | Sell |
120,142
-287,700
| -71% | -$11.5M | 0.23% | 59 |
|
2015
Q3 | $11.6M | Buy |
407,842
+95,000
| +30% | +$2.71M | 0.56% | 34 |
|
2015
Q2 | $10.3M | Buy |
312,842
+104,570
| +50% | +$3.45M | 0.4% | 57 |
|
2015
Q1 | $5.99M | Sell |
208,272
-261,703
| -56% | -$7.53M | 0.25% | 87 |
|
2014
Q4 | $12.8M | Buy |
469,975
+62,975
| +15% | +$1.71M | 0.56% | 46 |
|
2014
Q3 | $8.67M | Hold |
407,000
| – | – | 0.39% | 60 |
|
2014
Q2 | $9.14M | Buy |
407,000
+220,000
| +118% | +$4.94M | 0.35% | 70 |
|
2014
Q1 | $4.73M | Sell |
187,000
-289,200
| -61% | -$7.31M | 0.24% | 94 |
|
2013
Q4 | $10.9M | Sell |
476,200
-235,929
| -33% | -$5.42M | 0.5% | 45 |
|
2013
Q3 | $13.6M | Sell |
712,129
-36,975
| -5% | -$704K | 0.67% | 27 |
|
2013
Q2 | $10.8M | Buy |
+749,104
| New | +$10.8M | 0.64% | 23 |
|